NutriStack
Chromium and Empagliflozin, a caution.
Empagliflozin lowers blood glucose by causing urinary glucose excretion. Chromium independently improves insulin sensitivity. Used together the additive glucose-lowering is usually mild because SGLT2 inhibitors rarely cause hypoglycemia alone, but the risk rises when empagliflozin is part of a multi-drug regimen that already includes insulin or a sulfonylurea.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- Chromium and Empagliflozin
- Pair type
- Caution
- Evidence (highest tier)
- Emerging
- Source citations
- 2 sources
- Stack Score effect
- −5 to your Stack Score (per scored caution row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Caution · Emerging evidence
Caution
What is happening. Empagliflozin lowers blood glucose by causing urinary glucose excretion. Chromium independently improves insulin sensitivity. Used together the additive glucose-lowering is usually mild because SGLT2 inhibitors rarely cause hypoglycemia alone, but the risk rises when empagliflozin is part of a multi-drug regimen that already includes insulin or a sulfonylurea.
Mechanism. Empagliflozin inhibits sodium-glucose cotransporter 2 in the proximal renal tubule, reducing glucose reabsorption and producing glycosuria. Chromium amplifies post-receptor insulin signaling. Lowering hepatic glucose output and increasing peripheral glucose uptake compounds the renal glucose loss from empagliflozin.
Recommendation. If your only diabetes medication is empagliflozin, chromium can be added with home glucose monitoring during the first 2-4 weeks. If you also take insulin or a sulfonylurea, talk to your prescriber first about a dose reduction.
Sources (2)
- Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther. 2006;8(6):636-43. PMID 17109595
- Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:2-14. PMID 15208835
Stack Score
How this pair moves the number.
Effect on the composite score
If both Chromium and Empagliflozin are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.